Skyrizi 150mg, Injektionslösung im Fertigpen

7680681180012 CH-68118 Injektionslösung im Fertigpen
Skyrizi 150mg, Injektionslösung im Fertigpen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/01/2026
Patient information leaflet
Français
29/01/2026
Patient information leaflet
Italien
29/01/2026

Detailed composition

Substance Quantity Type Category
risankizumabum
150.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.209 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 3146.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2021

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
68118
Drug name
Skyrizi, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L04AC18
Authorization status
Z
Dispensing category
B
First authorization
07/07/2021
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis und Psoriasis-Arthritis bei Erwachsenen

Package details

Description (FR)
SKYRIZI Sol inj 150 mg/ml Stylo prér, 1pce
Description (DE)
SKYRIZI Inj Lös 150 mg/ml Fertpen, 1Stk
Market launch
07/07/2021
Narcotic (BTM)
No
Buy us a coffee Explore the data